GLP-1 Weight & Diabetes

Liraglutide

Once-daily GLP-1 injection for type 2 diabetes and weight management.

Liraglutide is a GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes and as an adjunct to diet and exercise for chronic weight management in individuals with obesity or overweight and related comorbidities. It works by enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite, leading to improved glycemic control and significant weight loss outcomes.

Ingredients dosages:

Frequency:

Quantity:

Not sure about dosages? Don't worry, your provider will adjust or confirm your selection after checkout.

Total

$0.00

Here's what happens next:

  1. 1

    Product checkout

    We'll direct you to our product detail page where you can start the checkout process. You'll be charged for the medical consultation but the medication charge is a hold until the official provider review.

  2. 2

    Comprehensive Medical Questionnaire

    After purchase, you'll be directed to a medical assessment covering your medical history, current medications, and specific symptoms.

  3. 3

    Licensed Provider Review

    A licensed healthcare provider reviews your complete medical profile, ensuring this treatment is safe and appropriate for you.

  4. 4

    Personalized Treatment Plan

    Your provider may recommend an adjustment to your prescription based on your full medical profile before approving your treatment.

HIPAA Compliant
Certified Providers
  • Lowers HbA1c by up to 1.5% in patients with type 2 diabetes

  • Supports average weight loss of 5-7% of body weight when combined with lifestyle changes

  • Reduces risk of major adverse cardiovascular events in patients with type 2 diabetes and high cardiovascular risk

  • Improves satiety and reduces caloric intake through delayed gastric emptying and central appetite regulation

  • Liraglutide: GLP-1 receptor agonist that increases glucose-dependent insulin secretion, reduces inappropriate glucagon secretion, delays gastric emptying, and enhances satiety

  • Inject subcutaneously once daily, at any time of day, independent of meals

  • Start with the dose prescribed by your provider, typically titrated upward to minimize GI side effects

  • Rotate injection sites (abdomen, thigh, upper arm)

  • Store unopened pens in the refrigerator; after first use, pens can be stored at room temperature for up to 30 days